More good news in the horizon for people with acromegaly

September 29, 2026

MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.

Arthritis and acromegaly

March 29, 2018

Arthropathy is one of the most insidious conditions that can affect people with acromegaly often with challenging quality of life issues.   Bone and joint issues are very common.  In this enlightening podcast, Dr. Lewis Blevins

Dan’s journey

December 30, 2017

I was fortunate to cross paths with Dan Jeffries a few weeks ago and chat with him about his journey with Acromegaly and a few other things. But I’ll let him tell you all about

Sleep apnea and acromegaly

December 19, 2017

Studies suggest that sleep apnea is a very common and potentially dangerous condition for people with acromegaly if not properly treated.  Today’s podcast presents an engaging look at sleep apnea.  PWN cofounders Dr. Lewis Blevins and Jorge

Sleep Apnea: nothing to snore about

December 8, 2017

PWN is developing a series of podcasts dedicated to sleep apnea, a very common related condition in people with active or controlled acromegaly and other pituitary conditions.  Stay tuned for an engaging series of doctor-patient

Anyone can get acromegaly: awareness is key

October 30, 2017

Here’s how you can get involved: Awareness is important because it is through awareness that we can influence change. Awareness can have a critical impact on the amount of time it takes to diagnose the